This reduction in FFAR3, due to the intestinal dysbiosis characteristic of obesity, compromises the bacterial production of SCFA and its ability to activate this receptor, thus affecting energy homeostasis and the secretion of intestinal hormones such as PYY and GLP-1 [48]. The gene discussed is FFAR3; the disease is obesity due to melanocortin 4 receptor deficiency.